The revenue will growth is key here. It is currently growing exponentially. Should be the last CR until cashflow positive or when they want to acquire another medical cannabis business globally.
The revenue will growth is key here. It is currently growing exponentially. Should be the last CR until cashflow positive or when they want to acquire another medical cannabis business globally.
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
